Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
出版年份 2016 全文链接
标题
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
作者
关键词
-
出版物
ACTA OPHTHALMOLOGICA
Volume 96, Issue 1, Pages e1-e9
出版商
Wiley
发表日期
2016-11-22
DOI
10.1111/aos.13325
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo
- (2016) Véronique Gebala et al. NATURE CELL BIOLOGY
- Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials
- (2016) John W. Kitchens et al. OPHTHALMOLOGY
- First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
- (2016) James S. Talks et al. OPHTHALMOLOGY
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2015) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2015) David M. Brown et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
- (2015) Peter A. Campochiaro et al. OPHTHALMOLOGY
- MICROPERIMETRIC ASSESSMENT OF RETINAL SENSITIVITY IN EYES WITH DIABETIC MACULAR EDEMA FROM A PHASE 2 STUDY OF INTRAVITREAL AFLIBERCEPT
- (2015) Victor H. Gonzalez et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models
- (2015) Valeria Cicatiello et al. Oncotarget
- Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
- (2014) Yuichiro Ogura et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
- (2014) Robert L Avery et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)
- (2014) Charles C Wykoff et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1α-VEGF Pathway Inhibition
- (2014) Hu Huang et al. DIABETES
- Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells
- (2014) Heidrun L. Deissler et al. EXPERIMENTAL EYE RESEARCH
- A safety evaluation of ranibizumab in the treatment of age-related macular degeneration
- (2014) Jonathan Mark Gibson et al. Expert Opinion On Drug Safety
- Relationship of Retinal Morphology and Retinal Sensitivity in the Treatment of Neovascular Age-Related Macular Degeneration Using Aflibercept
- (2014) F. Sulzbacher et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
- (2014) Jeffrey S. Heier et al. OPHTHALMOLOGY
- VEGF-Production by CCR2-Dependent Macrophages Contributes to Laser-Induced Choroidal Neovascularization
- (2014) Torsten A. Krause et al. PLoS One
- Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding
- (2014) Maria V Gelfand et al. eLife
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
- (2013) Vincent Y. Ho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Neuropilin 1 Cytoplasmic Domain Is Required for VEGF-A-Dependent Arteriogenesis
- (2013) Anthony Lanahan et al. DEVELOPMENTAL CELL
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
- (2013) Andrew A. Chang et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1
- (2012) Ying Zheng et al. ACTA OPHTHALMOLOGICA
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
- (2012) U Lassen et al. BRITISH JOURNAL OF CANCER
- KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF
- (2012) X. Chen et al. DIABETES OBESITY & METABOLISM
- The discovery of placenta growth factor and its biological activity
- (2012) Sandro De Falco EXPERIMENTAL AND MOLECULAR MEDICINE
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
- (2012) Christine Schmucker et al. PLoS One
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
- (2011) Laura Kowalczuk et al. PLoS One
- Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
- (2011) Hu Huang et al. PLoS One
- Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
- (2011) J. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Forty-Year Journey of Angiogenesis Translational Research
- (2011) Y. Cao et al. Science Translational Medicine
- Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
- (2010) C. Schmucker et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A Placental Growth Factor Variant Unable to Recognize Vascular Endothelial Growth Factor (VEGF) Receptor-1 Inhibits VEGF-Dependent Tumor Angiogenesis via Heterodimerization
- (2010) V. Tarallo et al. CANCER RESEARCH
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- (2010) Sara Van de Veire et al. CELL
- Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
- (2010) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: A link between angiogenesis and inflammation
- (2009) Seung-Ah Yoo et al. ARTHRITIS AND RHEUMATISM
- VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy
- (2009) R. Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular permeability, vascular hyperpermeability and angiogenesis
- (2008) Janice A. Nagy et al. ANGIOGENESIS
- Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels
- (2008) Shinji Ueno et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- PlGF-1 and VEGFR-1 Pathway Regulation of the External Epithelial Hemato-Ocular Barrier
- (2008) N. Miyamoto et al. OPHTHALMIC RESEARCH
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started